AzTrials
AzTrials

Hallux ValgusNCT02637362

Optimal Analgesia for Forefoot Surgery

A study testing Ankle block and Metatarsal block in people with Hallux Valgus and Conduction Block, run by Queen Elizabeth Hospital NHS Foundation Trust at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A randomised trial comparing three analgesic strategies for patients undergoing forefoot surgery in a day-surgery setting. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Hallux Valgus, Conduction Block
What is being tested?
Ankle block and Metatarsal block
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
69 participants
Where
1 siteUnited Kingdom
Study dates
2 Feb 2018to Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or female, aged 18 years or above.
  • Diagnosed with 1st metatarsal pathology requiring surgical correction
  • Participant meets the criteria for operative management in our day-surgery unit

Who cannot join

  • Contraindication to general anaesthesia
  • Diabetic neuropathy affecting lower limbs
  • Peripheral neuropathy affecting lower limbs of any aetiology
  • Revision surgery
  • Lack of capacity to consent

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site, 1 recruiting
  • Queen Elizabeth Hospital NHS Trust

    Kings Lynn, Norfolk, PE304ET

    James A Stimpson, MBChB, 01553613613 ext. 3583, jamesstimpson@btinternet.com

    Recruiting

Other trials in United Kingdom

About this study

Official title: Optimal Analgesia Following Metatarsal Surgery: A Prospective Randomised, Single-Blind Sham-Controlled Trial of Three Strategies

A randomised trial comparing three analgesic strategies for patients undergoing forefoot surgery in a day-surgery setting.

Read the detailed description

Forefoot surgery, including Scarf-Akin osteotomy surgery for bunion correction, is moderately painful orthopaedic surgery, commonly performed as a day-case procedure. Admission for opiate analgesia constitutes a failure of management and financial disadvantage to the healthcare organisation. The investigators seek to establish which technique will result in the best analgesia out of ankle block, metatarsal block, or a combination of the two. As analgesia constitutes part of a return to function, an additional aim is to determine whether either of these approaches will result in an objective functional benefit to the participants.

The trial seeks to recruit 23 patients into either of 3 groups: Ankle + sham metatarsal; sham Ankle + metatarsal; Ankle + Metatarsal.

Being tested
Ankle block, Sham ankle block, Metatarsal block, Sham metatarsal block
Medical subject headings
Hallux Valgus, Heart Block

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ankle blockProcedure or surgery

    Ultrasound guided ankle block of the tibial, superficial peroneal and deep peroneal nerves will be performed using a standardised technique

  • Sham ankle blockProcedure or surgery

    In the supine position with the hip and knee flexed, and the hip externally rotated, the skin from medial malleolus to Achilles tendon will be prepared with chlorhexidine 0.5% solution and allowed to dry. An ultrasound probe (linear array HFL25, Sonosite, Hitchin, UK) will be placed on a line from medial malleolus to achilles tendon to identify the posterior tibial artery and tibial nerve. A Stimuplex A50 needle (B-Braun) will be placed against the skin at the point at which the practitioner would normally have performed insertion of the needle. It will remain there for a total of 30 seconds and then will be removed.

  • Metatarsal blockProcedure or surgery

    A metatarsal block will be performed using a standardised technique

  • Sham metatarsal blockProcedure or surgery

    In the supine position, after the surgical incision has been sutured, a 25G standard bevel needle will be placed against the skin at the points at which the practitioner would normally have performed insertions of the needle. It will remain there for a total of 30 seconds and then be removed.

Study groups in NCT02637362
Study groupRoleWhat they receive
Ankle + Sham metatarsalActive comparatorAnkle block + sham metatarsal block
Receives: Procedure: Ankle block; Procedure: Sham metatarsal block
Ankle + MetatarsalActive comparatorAnkle block + metatarsal block
Receives: Procedure: Ankle block; Procedure: Metatarsal block
Metatarsal + sham ankleActive comparatorMetatarsal block + sham ankle block
Receives: Procedure: Sham ankle block; Procedure: Metatarsal block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Static pain score

    Visual Analogue scores

    Measured: 6 hours post-operatively

Secondary outcomes (8)
  1. Dynamic pain scores

    Visual Analogue scores

    Measured: 6 hours post-operatively

  2. Dynamic pain scores

    Visual Analogue scores

    Measured: Day 1 post-operatively

  3. Dynamic pain scores

    Visual Analogue scores

    Measured: Day 7 post-operatively

  4. Assessment of functional recovery

    Using Functional Recovery Index

    Measured: 6 hours post-operatively

  5. Assessment of functional recovery

    Using Functional Recovery Index

    Measured: Day 1 post-operatively

  6. Assessment of functional recovery

    Using Functional Recovery Index

    Measured: Day 7 post-operatively

  7. Static pain score

    Visual Analogue scores

    Measured: Day 1 post-operatively

  8. Static pain score

    Visual Analogue scores

    Measured: Day 7 post-operatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2015 (estimated)
  2. Study start2 Feb 2018
  3. Primary completionDec 2018 (estimated)
  4. Study completionJun 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
69 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02637362
Sponsor's protocol ID
JSCP1
Status last verified
Apr 2018
First submitted
16 Dec 2015
Last updated
1 May 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Ankle block and Metatarsal block in people with Hallux Valgus and Conduction Block, run by Queen Elizabeth Hospital NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact James A Stimpson, MBChB (+44 (01553) 613613 ext. 3583, james.stimpson@qehkl.nhs.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Static pain score (time frame: 6 hours post-operatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2018; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in